TRULIEVE CANNABIS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.37 CAD | +4.13% |
|
-3.43% | +109.78% |
| Apr. 22 | Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in North Palm Beach, Florida | MT |
| Apr. 22 | Trulieve to Open Medical Cannabis Dispensary in North Palm Beach, Florida | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,305 | 3,774 | 4,776 | 1,407 | 961.6 | 1,998 | - | - |
| Enterprise Value (EV) 1 | 1,346 | 3,727 | 4,763 | 2,020 | 961.6 | 2,235 | 2,422 | 1,998 |
| P/E ratio | 7.68 x | 59.5 x | 217 x | -5.78 x | -1.85 x | -24.5 x | -50.7 x | 43.7 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 5.16 x | 7.24 x | 5.09 x | 1.13 x | 0.85 x | 1.73 x | 1.63 x | 1.59 x |
| EV / Revenue | 5.32 x | 7.15 x | 5.08 x | 1.63 x | 0.85 x | 1.94 x | 1.97 x | 1.59 x |
| EV / EBITDA | 10.2 x | 14.9 x | 12.4 x | 5.05 x | 2.98 x | 6.75 x | 6.94 x | 5.37 x |
| EV / FCF | -26.3 x | -80.6 x | -18.1 x | -12.7 x | - | 11.6 x | 13.2 x | - |
| FCF Yield | -3.8% | -1.24% | -5.52% | -7.9% | - | 8.64% | 7.6% | - |
| Price to Book | 4.83 x | 8.34 x | 1.78 x | 0.74 x | - | 1.52 x | 1.46 x | 1.47 x |
| Nbr of stocks (in thousands) | 110,346 | 119,579 | 183,507 | 185,934 | 186,113 | 190,290 | - | - |
| Reference price 2 | 11.82 | 31.56 | 26.03 | 7.567 | 5.167 | 10.50 | 10.50 | 10.50 |
| Announcement Date | 4/8/20 | 3/23/21 | 3/30/22 | 3/8/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 252.8 | 521.5 | 938.4 | 1,240 | 1,129 | 1,154 | 1,229 | 1,253 |
| EBITDA 1 | 132.5 | 251 | 384.6 | 400.1 | 322.3 | 331.1 | 349 | 372.1 |
| EBIT 1 | 124.1 | 226.8 | 336.5 | 280.7 | 144.7 | 137.6 | 170.4 | 194.2 |
| Operating Margin | 49.09% | 43.49% | 35.86% | 22.64% | 12.81% | 11.92% | 13.86% | 15.5% |
| Earnings before Tax (EBT) 1 | 272.5 | 157.4 | 163.5 | -43.3 | -284.5 | 71.89 | 113.1 | 192.8 |
| Net income 1 | 178 | 63 | 18 | -246.1 | -526.8 | -80.91 | -33.21 | 139.6 |
| Net margin | 70.42% | 12.08% | 1.92% | -19.85% | -46.65% | -7.01% | -2.7% | 11.14% |
| EPS 2 | 1.540 | 0.5300 | 0.1200 | -1.310 | -2.790 | -0.4278 | -0.2071 | 0.2400 |
| Free Cash Flow 1 | -51.19 | -46.22 | -263 | -159.6 | - | 193.1 | 184.1 | - |
| FCF margin | -20.25% | -8.86% | -28.03% | -12.87% | - | 16.73% | 14.98% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | 58.32% | 52.74% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/8/20 | 3/23/21 | 3/30/22 | 3/8/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 224.1 | 305.3 | 318.3 | 320.3 | 300.8 | 302 | 289.1 | 281.8 | 275.2 | 287 | 285.8 | 286.7 | 285.8 | 291.4 | 288.7 |
| EBITDA 1 | 98.03 | 100.9 | 105.5 | 111 | 98.76 | 84.7 | 78.2 | 79 | 77.7 | 87.8 | 83.3 | 82.62 | 81.94 | 83.87 | 82.05 |
| EBIT 1 | 90.31 | 72.6 | 76.2 | 80.1 | 68.57 | 54 | 31.8 | 36.1 | 31.6 | 42.9 | 38.63 | 36.55 | 33.9 | 34.18 | - |
| Operating Margin | 40.3% | 23.78% | 23.94% | 25.01% | 22.8% | 17.88% | 11% | 12.81% | 11.48% | 14.95% | 13.52% | 12.75% | 11.86% | 11.73% | - |
| Earnings before Tax (EBT) 1 | 60.22 | -31.32 | 9.834 | 20.75 | -48.81 | -30.8 | -30.7 | -308.3 | 13.7 | 8.8 | 20.18 | 17.37 | 15.83 | 18.09 | 15.6 |
| Net income 1 | 18.62 | -71.5 | -32 | -22.5 | -114.6 | -77 | -64.1 | -403.8 | -25.4 | -33.4 | -19.02 | -20.92 | -21.7 | -20.15 | -25 |
| Net margin | 8.31% | -23.42% | -10.05% | -7.02% | -38.08% | -25.5% | -22.17% | -143.29% | -9.23% | -11.64% | -6.66% | -7.29% | -7.59% | -6.91% | -8.66% |
| EPS 2 | 0.1400 | -0.5600 | -0.1700 | -0.1200 | -0.6100 | -0.4100 | -0.3400 | -2.140 | -0.1400 | -0.1800 | -0.1000 | -0.1088 | -0.1150 | -0.1050 | -0.1300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 3/30/22 | 5/12/22 | 8/10/22 | 11/9/22 | 3/8/23 | 5/10/23 | 8/9/23 | 11/9/23 | 2/29/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 41.4 | - | - | 613 | - | 237 | 424 | - |
| Net Cash position 1 | - | 46.7 | 13.8 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.3127 x | - | - | 1.532 x | - | 0.7168 x | 1.215 x | - |
| Free Cash Flow 1 | -51.2 | -46.2 | -263 | -160 | - | 193 | 184 | - |
| ROE (net income / shareholders' equity) | 92.1% | 21.7% | 9.52% | -1.48% | - | -6.6% | -4.3% | - |
| ROA (Net income/ Total Assets) | 47.3% | 10.5% | 21.4% | -0.88% | - | -4.5% | -1.9% | - |
| Assets 1 | 376.5 | 601.1 | 83.99 | 27,843 | - | 1,798 | 1,748 | - |
| Book Value Per Share 2 | 2.450 | 3.790 | 14.60 | 10.30 | - | 6.900 | 7.180 | 7.160 |
| Cash Flow per Share 2 | 0.2000 | 0.8400 | 0.0800 | 0.1200 | - | 0.4300 | 0.9000 | - |
| Capex 1 | 74.7 | 99.9 | 276 | 183 | - | 67.6 | 35.7 | 30.5 |
| Capex / Sales | 29.55% | 19.16% | 29.4% | 14.74% | - | 5.86% | 2.9% | 2.43% |
| Announcement Date | 4/8/20 | 3/23/21 | 3/30/22 | 3/8/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
10.5
USD
Average target price
16.45
USD
Spread / Average Target
+56.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +109.78% | 2B | |
| +23.05% | 3.66B | |
| +87.30% | 61.69M |
- Stock Market
- Equities
- TRUL Stock
- Financials Trulieve Cannabis Corp.
